Literature DB >> 32206239

Interrupting cyclic dinucleotide-cGAS-STING axis with small molecules.

Herman O Sintim1,2,3, Clinton G Mikek1, Modi Wang1, Moloud A Sooreshjani1.   

Abstract

The cyclic dinucleotide-cGAS-STING axis plays important roles in host immunity. Activation of this signaling pathway, via cytosolic sensing of bacterial-derived c-di-GMP/c-di-AMP or host-derived cGAMP, leads to the production of inflammatory interferons and cytokines that help resolve infection. Small molecule activators of the cGAS-STING axis have the potential to augment immune response against various pathogens or cancer. The aberrant activation of this pathway, due to gain-of-function mutations in any of the proteins that are part of the signaling axis, could lead to various autoimmune diseases. Inhibiting various nodes of the cGAS-STING axis could provide relief to patients with autoimmune diseases. Many excellent reviews on the cGAS-STING axis have been published recently, and these have mainly focused on the molecular details of the cGAS-STING pathway. This review however focuses on small molecules that can be used to modulate various aspects of the cGAS-STING pathway, as well as other parallel inflammatory pathways. This journal is © The Royal Society of Chemistry 2019.

Entities:  

Year:  2019        PMID: 32206239      PMCID: PMC7069516          DOI: 10.1039/c8md00555a

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  121 in total

1.  Randomized phase III placebo-controlled trial of carboplatin and paclitaxel with or without the vascular disrupting agent vadimezan (ASA404) in advanced non-small-cell lung cancer.

Authors:  Primo N Lara; Jean-Yves Douillard; Kazuhiko Nakagawa; Joachim von Pawel; Mark J McKeage; Istvan Albert; György Losonczy; Martin Reck; Dae-Seog Heo; Xiaolin Fan; Abderrahim Fandi; Giorgio Scagliotti
Journal:  J Clin Oncol       Date:  2011-06-27       Impact factor: 44.544

2.  Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1.

Authors:  Richard I Feldman; James M Wu; Mark A Polokoff; Monica J Kochanny; Harald Dinter; Daguang Zhu; Sandra L Biroc; Bruno Alicke; Judi Bryant; Shendong Yuan; Brad O Buckman; Dao Lentz; Mike Ferrer; Marc Whitlow; Marc Adler; Silke Finster; Zheng Chang; Damian O Arnaiz
Journal:  J Biol Chem       Date:  2005-03-16       Impact factor: 5.157

Review 3.  Host-pathogen interactions during Mycobacterium tuberculosis infections.

Authors:  Sarah A Stanley; Jeffery S Cox
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

4.  cGAS and Ifi204 cooperate to produce type I IFNs in response to Francisella infection.

Authors:  Kelly M Storek; Nina A Gertsvolf; Maikke B Ohlson; Denise M Monack
Journal:  J Immunol       Date:  2015-02-20       Impact factor: 5.422

5.  Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.

Authors:  Leticia Corrales; Laura Hix Glickman; Sarah M McWhirter; David B Kanne; Kelsey E Sivick; George E Katibah; Seng-Ryong Woo; Edward Lemmens; Tamara Banda; Justin J Leong; Ken Metchette; Thomas W Dubensky; Thomas F Gajewski
Journal:  Cell Rep       Date:  2015-05-07       Impact factor: 9.423

6.  ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization.

Authors:  Wenxiang Sun; Yang Li; Lu Chen; Huihui Chen; Fuping You; Xiang Zhou; Yi Zhou; Zhonghe Zhai; Danying Chen; Zhengfan Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

7.  Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.

Authors:  Scott J Antonia; Augusto Villegas; Davey Daniel; David Vicente; Shuji Murakami; Rina Hui; Takashi Yokoi; Alberto Chiappori; Ki H Lee; Maike de Wit; Byoung C Cho; Maryam Bourhaba; Xavier Quantin; Takaaki Tokito; Tarek Mekhail; David Planchard; Young-Chul Kim; Christos S Karapetis; Sandrine Hiret; Gyula Ostoros; Kaoru Kubota; Jhanelle E Gray; Luis Paz-Ares; Javier de Castro Carpeño; Catherine Wadsworth; Giovanni Melillo; Haiyi Jiang; Yifan Huang; Phillip A Dennis; Mustafa Özgüroğlu
Journal:  N Engl J Med       Date:  2017-09-08       Impact factor: 91.245

8.  Cyclic [G(2',5')pA(3',5')p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase.

Authors:  Pu Gao; Manuel Ascano; Yang Wu; Winfried Barchet; Barbara L Gaffney; Thomas Zillinger; Artem A Serganov; Yizhou Liu; Roger A Jones; Gunther Hartmann; Thomas Tuschl; Dinshaw J Patel
Journal:  Cell       Date:  2013-05-03       Impact factor: 41.582

9.  Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent.

Authors:  M B Jameson; P I Thompson; B C Baguley; B D Evans; V J Harvey; D J Porter; M R McCrystal; M Small; K Bellenger; L Gumbrell; G W Halbert; P Kestell
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

Review 10.  STING: infection, inflammation and cancer.

Authors:  Glen N Barber
Journal:  Nat Rev Immunol       Date:  2015-12       Impact factor: 53.106

View more
  7 in total

1.  Molecular Dynamics Simulations Reveal the Modulated Mechanism of STING Conformation.

Authors:  Li Chen; Shuang Zhao; Yanyan Zhu; Yongsheng Liu; Huiyu Li; Qingjie Zhao
Journal:  Interdiscip Sci       Date:  2021-06-17       Impact factor: 2.233

Review 2.  Regulation and inhibition of the DNA sensor cGAS.

Authors:  Jonny Hertzog; Jan Rehwinkel
Journal:  EMBO Rep       Date:  2020-11-05       Impact factor: 9.071

3.  Global proteomics of fibroblast cells treated with bacterial cyclic dinucleotides, c-di-GMP and c-di-AMP.

Authors:  Kenneth I Onyedibe; Samira Elmanfi; Uma K Aryal; Eija Könönen; Ulvi Kahraman Gürsoy; Herman O Sintim
Journal:  J Oral Microbiol       Date:  2021-12-29       Impact factor: 5.474

4.  Network Pharmacology-Based Systematic Analysis of Molecular Mechanisms of Geranium wilfordii Maxim for HSV-2 Infection.

Authors:  Hao Zhang; Ming-Huang Gao; Yang Chen; Tao Liu
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-03       Impact factor: 2.629

Review 5.  The role of bacterial cyclic di-adenosine monophosphate in the host immune response.

Authors:  Xingqun Cheng; Jia Ning; Xin Xu; Xuedong Zhou
Journal:  Front Microbiol       Date:  2022-08-29       Impact factor: 6.064

Review 6.  Bacterial Cyclic Dinucleotides and the cGAS-cGAMP-STING Pathway: A Role in Periodontitis?

Authors:  Samira Elmanfi; Mustafa Yilmaz; Wilson W S Ong; Kofi S Yeboah; Herman O Sintim; Mervi Gürsoy; Eija Könönen; Ulvi K Gürsoy
Journal:  Pathogens       Date:  2021-05-30

Review 7.  Crosstalk Between Dysfunctional Mitochondria and Inflammation in Glaucomatous Neurodegeneration.

Authors:  Assraa Hassan Jassim; Denise M Inman; Claire H Mitchell
Journal:  Front Pharmacol       Date:  2021-07-21       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.